Allergan is a world leader in medical aesthetics, neuromodulator therapy and neurosciences. For nearly two decades, we have been committed to the research and clinical development of BOTOX® (onabotulinumtoxinA), one of the world's most versatile medicines, to help improve the physical well-being of people around the world who suffer from a variety of serious or debilitating disorders. BOTOX® is currently available in approximately 75 countries.
Building on our heritage, Allergan is now pursuing advanced research to develop "next-generation" neuromodulator therapies and other treatments for neurological conditions.
We offer a comprehensive, science-based facial aesthetic portfolio that includes BOTOX® Cosmetic (onabotulinumtoxinA) the JUVÉDERM® family of dermal filler products.
| Trade name |
Description |
Global Site Reference ONLY |
| JUVEDERM® |
The JUVÉDERM® family of hyaluronic acid dermal fillers provides correction of moderate to severe facial wrinkles and folds. |
Go to site |
| BOTOX® |
BOTOX® (onabotulinumtoxinA), one of the world's most versatile medicines, to help improve the physical well-being of people around the world who suffer from a variety of serious or debilitating disorders. |
Go to site |